Evidence map›Paper›PMID 37293956›Full record

ArticleAmerican journal of medical genetics. Part A2023

Exome sequencing in a Romanian Bardet-Biedl syndrome cohort revealed an overabundance of causal BBS12 variants.

Sheraz Khan, Ina Ofelia Focșa, Magdalena Budișteanu, Cristina Stoica, Florina Nedelea, Laurențiu Bohîlțea, Lavinia Caba, Lăcrămioara Butnariu, Monica Pânzaru, Cristina Rusu and 8 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Sheraz KhanStanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Ina Ofelia FocșaUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Magdalena BudișteanuPsychiatry Research Laboratory, "Prof. Dr. Alexandru Obregia" Clinical Hospital of Psychiatry, Bucharest, Romania.
Cristina StoicaUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Florina NedeleaUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Laurențiu BohîlțeaUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Lavinia CabaDepartment of Medical Genetics, "Grigore T. Popa" University of Medicine and Pharmacy, Iași, Romania.
Lăcrămioara ButnariuDepartment of Medical Genetics, "Grigore T. Popa" University of Medicine and Pharmacy, Iași, Romania.
Monica PânzaruDepartment of Medical Genetics, "Grigore T. Popa" University of Medicine and Pharmacy, Iași, Romania.
Cristina RusuDepartment of Medical Genetics, "Grigore T. Popa" University of Medicine and Pharmacy, Iași, Romania.
Claudia JurcăDepartment of Genetics, Faculty of Medicine and Pharmacy, University of Oradea, Oradea, Romania.
Adela Chirita-EmandiEmergency Hospital for Children Louis Turcanu, Regional Center of Medical Genetics Timis, Timisoara, Romania.ORCID 0000-0001-7554-4625
Claudia Bănescu"George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology, Târgu Mureş, Romania.
Wasim AbbasHuman Molecular Genetics Lab, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE-C), Faisalabad, Pakistan.
Azita SadeghpourCenter for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA.
Shahid Mahmood BaigPakistan Science Foundation (PSF), Islamabad, Pakistan.
Mihaela BălgrădeanUniversity of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Erica E DavisStanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.ORCID 0000-0002-2412-8397
Carol Davila University of Medicine and Pharmacy · ROGrigore T. Popa University of Medicine and Pharmacy · ROAga Khan University · PKDuke University · USLurie Children's Hospital · USNational Institute for Biotechnology and Genetic Engineering · PKNorthwestern University · USTitu Maiorescu University · ROUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROUniversity of Oradea · ROVictor Babeș University of Medicine and Pharmacy Timișoara · RO

Funding

Molecular Genetics of BBSR01HD042601 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2003 to 2023
$8.2M
Genetic and Functional Studies of Human Ciliary SyndromesR01DK072301 · NIDDK · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2005 to 2022
$7.2M
NICHD NIH HHS R01 HD042601NIDDK NIH HHS R01 DK072301
6 · The paper itself

Abstract

Bardet-Biedl syndrome (BBS), is an emblematic ciliopathy hallmarked by pleiotropy, phenotype variability, and extensive genetic heterogeneity. BBS is a rare (~1/140,000 to ~1/160,000 in Europe) autosomal recessive pediatric disorder characterized by retinal degeneration, truncal obesity, polydactyly, cognitive impairment, renal dysfunction, and hypogonadism. Twenty-eight genes involved in ciliary structure or function have been implicated in BBS, and explain the molecular basis for ~75%-80% of individuals. To investigate the mutational spectrum of BBS in Romania, we ascertained a cohort of 24 individuals in 23 families. Following informed consent, we performed proband exome sequencing (ES). We detected 17 different putative disease-causing single nucleotide variants or small insertion-deletions and two pathogenic exon disruptive copy number variants in known BBS genes in 17 pedigrees. The most frequently impacted genes were BBS12 (35%), followed by BBS4, BBS7, and BBS10 (9% each) and BBS1, BBS2, and BBS5 (4% each). Homozygous BBS12 p.Arg355* variants were present in seven pedigrees of both Eastern European and Romani origin. Our data show that although the diagnostic rate of BBS in Romania is likely consistent with other worldwide cohorts (74%), we observed a unique distribution of causal BBS genes, including overrepresentation of BBS12 due to a recurrent nonsense variant, that has implications for regional diagnostics.

Indexed as

Bardet-Biedl SyndromeCytoskeletal ProteinsExome SequencingHomozygoteHumansMutationPhosphate-Binding ProteinsRomaniaBBS5 protein, humanCytoskeletal ProteinsPhosphate-Binding Proteinsciliopathypleiotropypolydactylyretinal dystrophysecond-site modifiersurogenital malformations

Identifiers

PMID37293956
PMCPMC10524726
OpenAlexW4379966626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.